| 1 | Development of Sugar Free Dosage Forms, Quality Control and Pharmacological Evaluation of Khamira Banafsha, Khamira Aabresham, Laooq-e-Katan, Sharbat Toot Siyah, Laooq Sapistan and Sharbat Zoofa against Covid -19 related disorders | Khamira Banafsha, Khamira Aabresham, Laooq-e-Katan, Sharbat Toot Siyah, Laooq Sapistan and Sharbat Zoofa |
| 2 | Pharmacokinetics, stability and quality control studies on Itrifal’s of the Unani Pharmacopoeia of India (Part 2 Vol.1 & Vol.2) using Chromatographic Analysis by HPTLC and LC-MS | Itrifal Zamani, Itrifal-e-Muqil, ItrifalMulayan, ItrifalMuqawwiDimagh, Itrifal-e-MuqilMumsik, Itrifal-e-Mushil, Itrifal-e-Sana, Itrifal-e-Zabeeb, Itrifal Zamani |
| 3 | In vitro Evaluation of Antiviral activity of Unani Drugs and their Green Nano-particles against Dengue Virus. | Afsanteen, Gilo, Gul e Nilofer and Khaksi, Habb-e-Papita, Sharbat Anjbarand, Khamira Marwareed |
| 4 | “Preclinical evaluation of UNIM-401 and UNIM-403 against experimentally induced psoriasis and UNIM-004 and UNIM-005 for their efficacy against experimentally induced vitiligo in mice” | UNIM-401 and UNIM-403
UNIM-004 and UNIM-005 |
| 5 | Targeting Alzheimer’s disease by a mixture of Unani plant extract via modulation of human kinase | Dried root of Withania somnifera (Asgandh), leaves and stems of Bacopa mon11ieri (Brahmi), fruits of Terminalia chebula (Halela siyah), and oleo-gum resins of Boswellia serrate (Kundur) |
| 6 | Drug proving studies, mechanistic insight and development of novel drug delivery systems of UNIM H and UNIM R used in the treatment of Arthritis in the Unani system of Medicine | UNIM H and UNIM R |
| 7 | Investigating and validation of the molecular mechanism of Unani medicines in vitro and in vivo for the treatment of Atopic Dermatitis. | Barg-e-shahtra, Babchi, Badaam, Sheerin, Tukhme khurfa, and Halela Siyah |
| 8 | Evaluation of anti tubercular and immune-modulatory activities of Unani Pharmacopoeial formulations (UPF) Qurs Tabasheer Sartani and Arq e Hara Bhara through in vitro and in vivo studies. | Qurs Tabasheer Sartani and Arq e Hara Bhara |
| 9 | Pharmacological activities and pre clinical screening of the promising Unani medicines against hepatic diseases. | Saad Koofi (Cyperus rotundus) and Mastagi (Pistacia lentiscus) |
| 10 | Determination of anti-aging and antioxidant potential of a Unani formulation | Habb-e- Asgandh |
| 11 | Evaluation of immune modulatory and antioxidant potential of a Unani formulation | Tiryaq-e- Samaniya |
| 12 | Investigation of hepatoprotective activity of Unani Formulations with emphasis on alleviation of antitubercular drugs' induced hepatotoxicity: Elucidation of molecular mechanism | Qurs e Afsanteen and Safoof e Jigar |
| 13 | Redesigning and pharmacological evaluation of some classical Unani formulations with specific reference to immune-modulatory 1activity, safety profile and stability studies | Dawa-ul-Kurkum, Halwa Gheekwar, ltrefal Ustkhudus |
| 14 | Chemotherapeutic effect of a selected Unani Medicine in xenograft mouse model of lung cancer | Joshanda-e-Aftimun |
| 15 | Evaluation of hepato protective efficacy and underlying molecular mechanism of CCRUM formulations, in experimental animal models of Anti-tuberculosis drug-induced liver injury (ATDILI):A pre-clinical study | Sumbul ut teeb, Afsanteen, Majeeth, Gul surkh, Revand chini, Mastagi, Filfil siyah |
| 16 | Assessment on the modulation of Anticancer activity of Standard Cancer Drugs by Nutraceuticals and Unani drug in colorectal cancer” | Majun Sangdana Murgh, Coriandrum sativum and Trachyspermm ammi |
| 17 | Unravelling the cardioprotective mechanism of Khamira Abresham Hakim Arshad Wala using in-silico, in-vitro and in-vivo (New Zealand Rabbit) system: A step towards planning a clinical trial with Unani formulation for cardioprotection | Fruit rind of Halela Zard, Fruit rind of Halela Kabuli, Halela Siyah, Fruit rind of BaleIa, Drv fruit of Amla, Gule Surkh, Anisoon, Gule Gaozaban, Kishneez Khushk, UNIM CP-1 (Majoon) |
| 18 | Redesigning & Evaluation of Antifungal potential and Mechanism of action of Marham Hina, a Unani pharmacopoeial formulation against Resistant Candida stains and Dermatophytes” | Marham Hina |
| 19 | Preparation of sugar-free Khamira-e-Gaozaban Sada (sf KGS) and it’s comparison with the Unani drug (KGS) for their immunomodulatory potential against the in vivo model of maniac phase of bipolar disorder (BD) | Khamira-e- Gaozaban Sada (sf KGS) (lab prepared sugar free and marketed) |
| 20 | Effect of Unani Formulations against Mitochondrial Mediated Cellular Mechanisms: A strategy to combat Alzheimer’s Disease | Majun Falsafa, Majoon-e-Bhrami, Majoon-e-Baladur |
| 21 | Formulation, Development and Preclinical evaluation of novel Unani dispersible tablets for Immunomodulatory activity and as adjuvant to Anticancer therapy | Zanjabeel (Sonth), Zard Chob/Aamba Haldi, Asl-ul-Soos, Filfil Siyah, Hulba, Samagh-e- Arabi, Rewand Chini |
| 22 | Evaluation of Unani formulation-Harira for improving mental retardation and exploration of underlying molecular mechanisms using animal model | Harira |
| 23 | Development and Evaluation of New Intranasal Nano formulation of Anti-epileptic Unani Medicinal Herbs | Ood saleeb, Ustukhudoos, Habb-e-balsan |
| 24 | To Perform Shelf Life studies and Animal safety Studies of selected Unani Formulations as per ICH/OECD Guidelines” | Majoon Suparipak, Khameera Gaozaban ambri, Majoon Suranjan, Khameera Aabresham Sada, Majoon Chobchini |
| 25 | Preclinical and clinical studies to evaluate the safety and efficacy of topical Unani formulation in Dermatophytosis | Unani paste (Kibreet, Suhaga, Naushadar, AhakeAabRase eda, Seer, Mazu |
| 26 | Local application of Novel Unani gel/Paste formulation for medical management of Oral submucous fibrosis (OSF): A randomized controlled clinical trial | Alsi, Rub-us- SooSSiyah, FilfilSiyah, Gond Keekar, Magz-e-Badam Shireen, Maghz-e- Akhrot |
| 27 | Pharmacokinetic and pharmacodynamics studies of Habb e Asgand- a clinically used anti-arthritic Unani formulation | Habb e Asgand |
| 28 | Preclinical and Immunotherapeutic assessment of Majoon Najah an Unani Formulation in Cervical Carcinoma | Majoon Najah |
| 29 | Study and validation of the anticancer potential of prominent Unani medicines Arq Makoh and Arq Kasni and their nano formulations against liver carcinoma | Arq Makoh and Arq Kasni |
| 30 | A randomised Controlled trial comparing Unani medicine plus standard of care vs Standard of care in reducing exacerbations in COPD patients | Sufoof Kakra Singhi (Kakrasingi, Zanjabeel, Filfil-e-daraz) |
| 31 | Evaluation of Unani Polyherbal formulations, acting as Muqawwi Dimagh for their potential to inhibit Acetylcholinesterase and ameliorate Beta-amyloid toxicity | Majoon-e-Bolas, Majoon-e-Baladur, Majoon-e-Falasifa |
| 32 | Design, Development and Evaluation of Novel Immunodulatory RTD (Ready to Dispense) formulations UNIM 2020A and UNIM 2020B | UNIM 2020A and UNIM 2020B |
| 33 | Development of chemical profile and identification of bioactive & chemical markers for authentication and elite identification of the selected Unani herbal drugs | Unnab, Sapistan, Behidana |
| 34 | Evaluation of Unani Drug on FoxP3 expressing regulatory T Cells in the modulation of rheumatoid arthritis | Majun Jograj Gugal, Majun Suranjan, Majun Chob Chini Ba Nuskha Kalan |
| 35 | Effect of Selected Unani formulation on oxidative stress in patients with type 2 diabetes mellitus a randomized double-blind placebo controlled clinical trial | Qurs-e-Ziabetus Sada |
| 36 | Design and Development of a Standardized Dry and Wet Cupping Therapy Device: An Efficient way to perform Cupping Therapy | Automated Design of Cupping Device |
| 37 | Evaluation of a Unani Polyherbal formulation, acting as a brain tonic, and its constituents for potential Anti-Alzheimer activity | Jawarish Shahi |
| 38 | Molecular mechanisms and effect of Cardioprotective Unani drugs Khamira Abresham, Dawa-ul-Misk Motadil and Khamira Gawzaban on Nitric Oxide (NO) production, uncoupling and reactive oxygen species (ROS) generation in Atherosclerosis | Khamira Abresham, Dawa-ul-Misk Motadil and Khamira Gawzaban |
| 39 | Exploring the therapeutic potential of Majoon Ushba, and Unani Medicine against psoriasis (Dau-S-Sadaf) with reference to IL-17 acytokine signalling | Majoon Ushba, Arq murakkab mussaffi khoon |
| 40 | Investigate the Therapeutic and Chemo-Sensitizing Efficacy of Unani Pharmacopoeial formulation Dawa-ul-Kurkum on Head and Neck Squamous Cell Carcinoma | Dawa-ul-Kurkum |
| 41 | Colon targeting of Unani Medicine via gum (polysaccharide) based oral formulations for effective treatment of irritable bowel syndrome: Clinical Intervention by Gamma Scintigraphy | Jawarish Shahi |
| 42 | To investigate the Pharmacological effect of certain Unani formulations in a Preclinical animal model of Polycystic Ovary Syndrome | Arq-e-qasni, Arq-e-mako, Majoon Dabid-ul-ward |
| 43 | Design and Development of Sharbat Ahmad Shahi in to Tablet alongwith its Physico-pharmaceutical and Pharmacological evaluation | Sharbat Ahmad Shahi |
| 44 | Assessment of the effect of Unani formulation loaded nanoparticle tablets against Streptozotocin-induced Diabetes | Qurs Gulnar nanoparticles |
| 45 | Preclinical and clinical validation of safety and efficacy of traditional Unani formulation Sharbath Mundi pertaining to its hepatoprotective effect | Sharbath Mundi |
| 46 | Phytochemical Profiling, Assessment of Safety, and Validation of Anti-amnestic Effect of the Majoon Boolis: a Preclinical Investigation | Majoon Boolis |
| 47 | Anti-diabetic and Immune-modulatory effect of Unani formulation “Safuf-i-Dhayabitus’ | Safuf-i-Dhayabitus’ |
| 48 | Studies on Evaluating the Anti-Fibrotic Potential of a Unani Formulation (Majusi Formula) | Majusi Formula |
| 49 | Effect of Unani drugs on the transgenic drosophila model flies of Parkinson’s disease | Khamira Gawzaban Ambari Jadwar Ood Saleeb vala |
| 50 | Structural characterization, pharmacokinetics, pharmacodynamic and herb-drug interactions of major constituents of compound Unani formulation for diabetes | Compound Unani formulation (CUF) |
| 51 | Evaluation of safety and efficacy of Unani Pharmacopeial formulation(s) as a therapeutic adjuvant to antiepileptic drugs in drug resistant epilepsy | Khamira-i Gāozaban Ambari Jadwar ood Salib Wala and Majoon-e Najah |
| 52 | Anticancer efficacy and molecular basis of Dawa-ul-Kurkum on the tumorigenesis of pancreatic ductal adenocarcinoma | Dawa-ul-Kurkum |
| 53 | Novel Unani Medicine infused Organic Oil based in-soles for diabetic foot care | Zaroor-e-Qawi |
| 54 | Evaluation of Munḍij-i-Balgham and Mushil-i-Balgham Unani Formulations in Cerebral Ischemic Stroke | Mä’ al-‘Asal, Munḍij-i-Balgham (Aslussoos, Badyan, Beekhe Badyan, Ustukhuddoos, Anisoon, Tukhme Karafs, Ood Saleeb, Beekhe Izkhar, Barge Gaozaban), Mushil-i-Balgham (Ustukhuddoos, Barge Sana, Turbud, Maghz Fuloos Khayar Shambar, Raughane Zard) |
| 55 | Gut microbiota heterogeneity in association with Obesity and T2DM and the intervention of Unani medicinal drug Qurse-Ziabetus on gut microbiota | Qurse-Ziabetus Khaas and Safoof Ziabetes |
| 56 | Harnessing Unani Medicines in an Emulgel Formulation for Managing Imiquimod-Induced Human Plaque-Type Psoriasis in Pre-Clinical Testing | UNIM-402 loaded emulgel formulation |
| 57 | Development of a DNA barcode library of plant origin single drugs of Unani Pharmacopoeia for authentication of plant species used in Unani system of medicine | List of 100 medicinal plants |
| 58 | Establishment of Quality Standards, In vivo Anxiolytic Activity and Formulation Development of Natural Sweetener based Syrup of some Unani Drugs | Novel Formulation |
| 59 | Formulation and Evaluation of Nanostructure Lipid Carrier Based Transdermal Gel for Polycystic Ovary Syndrome (PCOS) and Associated Complications | Habb-e-mudir, Majoon Muqawwi Rahem and Majoon-e- Dabidul-ward |
| 60 | Standardization and validation of Khamira Abresham & Khamira Marwareed for Isoprotrenol induced Myocardial Infarction via eNOS and ROS generation through Nano Drug delivery System | Khamira Abresham & KhamiraMarwareed |
| 61 | Exploring the anti-cancer potential of a Unani Drug toot-e-siyah (Morus nigra) on mice models | toot-e-siyah (Morusnigra) |
| 62 | Pharmacological and Molecular Investigations of Qurs Zarishk Haar in the Model of Alcohol-Induced Hepatitis | Qurs Zarishk Haar |
| 63 | Evaluation of the Osteogenic potential and safety of Unani Formulations Majun Falasifa and Kushta-e- Gaudanti in Osteopenia Model. | Majun Falasifa and Kushta-e- Gaudanti |
| 64 | A preliminary randomized controlled trial to test the safety & efficacy of Unani formulation in patients suffering from Ulcerative colitis | Bihidāna (Cydonia oblonga Mill. seeds) |
| 65 | Exploration of Combinatorial Therapy of Unani Drugs Irsa, Hasha, and Anisun as Multitarget Approach for PCOS and Associated Metabolic Disorders in Pre-Clinical Model | Irsa, Hasha, and Anisun |
| 66 | Effect of Unani Formulations (Dawa-e-Sahaj, Jawarish-e-Mastagi, Qurs-e-Gul) for the Inhibition of NLRP3 inflammasome activation: A strategy to mitigate inflammation for the therapy of Ulcerative Colitis disease. | Dawa-e-Sahaj, Jawarish-e-Mastagi, Qurs-e-Gul |
| 67 | Harnessing Classical Unani Medicine to Combat Aging-associated Muscle Wasting: an in silico, in vitro, and in vivo approach | Majoon-e-Araad Khurma, Laboob-e-Sagheer, Majoon-e Falasafa, Khamira Gawzaban Sada, Khamira Abresham Sada and Khamira Marwarid |
